Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SANUWAVE Health (SNWV) Consolidated Net Income (2016 - 2026)

SANUWAVE Health has reported Consolidated Net Income over the past 17 years, most recently at -$1.7 million for Q1 2026.

  • Quarterly Consolidated Net Income fell 27.68% to -$1.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Mar 2026, up 183.05% year-over-year, with the annual reading at $11.8 million for FY2025, 135.71% up from the prior year.
  • Consolidated Net Income was -$1.7 million for Q1 2026 at SANUWAVE Health, down from $7.6 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $18.2 million in Q4 2023 and troughed at -$23.7 million in Q3 2023.
  • The 5-year median for Consolidated Net Income is -$1.7 million (2026), against an average of -$2.4 million.
  • Year-over-year, Consolidated Net Income plummeted 1980.77% in 2023 and then surged 1588.06% in 2025.
  • A 5-year view of Consolidated Net Income shows it stood at -$5.7 million in 2022, then surged by 420.76% to $18.2 million in 2023, then crashed by 102.8% to -$511000.0 in 2024, then surged by 1588.06% to $7.6 million in 2025, then crashed by 121.96% to -$1.7 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Consolidated Net Income are -$1.7 million (Q1 2026), $7.6 million (Q4 2025), and -$892000.0 (Q3 2025).